MENDI SAYER: Open Payments
NPI 1538848072 · ANGLETON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 33 payments from 11 companies in 2025. Trend: 2023 $456 · 2024 $794 · 2025 $712
Food & beverage: $640Education: $71
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| Teva Pharmaceuticals USA, Inc. | 2 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Lundbeck LLC | 3 | $69 |
| Almatica Pharma LLC | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Bausch Health US, LLC | 3 | $52 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $36 |
Products named: REXULTI, VRAYLAR, CAPLYTA, LOREEV XR, Auvelity, APLENZIN, Qelbree, ARISTADA.
Industry payments across TX — which companies pay providers there.
